|

AZD9574 Clinical Trials

3 actively recruiting trials across 3 locations

Pipeline

Phase 1/2: 3

Top Sponsors

  • AstraZeneca3

Indications

  • Cancer3
  • Lung Adenocarcinoma1
  • Metastatic Prostate Cancer1
  • Endometrial Cancer1
  • Advanced Solid Malignancies1

Fayetteville, Arkansas1 trial

Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer

Research Site

Phase 1/2

Duarte, California1 trial

Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors

Research Site

Phase 1/2

La Jolla, California1 trial

Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies

Research Site

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.